메뉴 건너뛰기




Volumn 10, Issue 4, 2008, Pages 379-384

What is the evidence for the use of probiotics in functional disorders?

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; VSL3;

EID: 52049100954     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-008-0072-1     Document Type: Review
Times cited : (12)

References (64)
  • 1
    • 0031768678 scopus 로고    scopus 로고
    • Creating and maintaining the gastrointestinal ecosystem: What we know and need to know from gnotobiology
    • Falk PG, Hooper LV, Mittvedt T, Gordon JI: Creating and maintaining the gastrointestinal ecosystem: What we know and need to know from gnotobiology. Microbiol Mol Biol Rev 1998, 62: 1157-1170.
    • (1998) Microbiol Mol Biol Rev , vol.62 , pp. 1157-1170
    • Falk, P.G.1    Hooper, L.V.2    Mittvedt, T.3    Gordon, J.I.4
  • 2
    • 0036885585 scopus 로고    scopus 로고
    • The host-microbe interface within the gut
    • Shanahan F: The host-microbe interface within the gut. Best Pract Res Clin Gastroenterol 2002, 16: 915-931.
    • (2002) Best Pract Res Clin Gastroenterol , vol.16 , pp. 915-931
    • Shanahan, F.1
  • 3
    • 33947119626 scopus 로고    scopus 로고
    • Gut microbiota: Mining for therapeutic potential
    • O'Hara AM,MShanahan F: Gut microbiota: mining for therapeutic potential. Clin Gastroenterol Hepatol 2007, 5: 274-284.
    • (2007) Clin Gastroenterol Hepatol , vol.5 , pp. 274-284
    • O'Hara, A.M.1    Shanahan, F.2
  • 4
    • 0037425743 scopus 로고    scopus 로고
    • Gut flora in health and disease
    • Guarner F, Malagelada JR: Gut flora in health and disease. Lancet 2003, 361: 512-519.
    • (2003) Lancet , vol.361 , pp. 512-519
    • Guarner, F.1    Malagelada, J.R.2
  • 5
    • 10744233159 scopus 로고    scopus 로고
    • Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis
    • Rachmilewitz D, Katakura K, Karmeli F, et al.: Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126: 520-528.
    • (2004) Gastroenterology , vol.126 , pp. 520-528
    • Rachmilewitz, D.1    Katakura, K.2    Karmeli, F.3
  • 6
    • 0037951267 scopus 로고    scopus 로고
    • Probiotics: A perspective on problems and pitfalls
    • ShanahAn F: Probiotics: a perspective on problems and pitfalls. Scand J Gastroenterol 2003, 38(suppl): 34-36.
    • (2003) Scand J Gastroenterol , vol.38 , Issue.SUPPL. , pp. 34-36
    • Shanahan, F.1
  • 8
    • 33750016634 scopus 로고    scopus 로고
    • Clinical efficacy of probiotics: Review of the evidence with focus on children
    • NASPGHAN Nutrition Report Committee, Michail S, Sylvester F, et al.:
    • NASPGHAN Nutrition Report Committee, Michail S, Sylvester F, et al.: Clinical efficacy of probiotics: Review of the evidence with focus on children. J Pediatr Gastroenterol Nutr 2006, 43: 550-557.
    • (2006) J Pediatr Gastroenterol Nutr , vol.43 , pp. 550-557
  • 9
    • 43649100298 scopus 로고    scopus 로고
    • Bacterial flora in irritable bowel syndrome: Role in pathophysiology, implications for management
    • Quigley EM: Bacterial flora in irritablR bowel syndrome: role in pathophysiology, implications for management. J Dig Dis 2007, 8: 2-7.
    • (2007) J Dig Dis , vol.8 , pp. 2-7
    • Quigley, E.M.1
  • 10
    • 34547477105 scopus 로고    scopus 로고
    • Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome
    • Thabane M, Kottachchi DT, Marshall JK: Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007, 26: 535-544.
    • (2007) Aliment Pharmacol Ther , vol.26 , pp. 535-544
    • Thabane, M.1    Kottachchi, D.T.2    Marshall, J.K.3
  • 11
    • 34147130268 scopus 로고    scopus 로고
    • Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen
    • Marshall JK, Thabane M, Borgaonkar MR, James C: Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol 2007, 5: 457-460.
    • (2007) Clin Gastroenterol Hepatol , vol.5 , pp. 457-460
    • Marshall, J.K.1    Thabane, M.2    Borgaonkar, M.R.3    James, C.4
  • 12
    • 0033056598 scopus 로고    scopus 로고
    • The role of psychological and biological factors in post-infective gut dysfunction
    • Gwee K-A, Leong Y-L, Graham C, et al.: The role of psychological and biological factors in post-infective gut dysfunction. Gut 1999, 44: 400-406.
    • (1999) Gut , vol.44 , pp. 400-406
    • Gwee, K.-A.1    Leong, Y.-L.2    Graham, C.3
  • 13
    • 0345059404 scopus 로고    scopus 로고
    • Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS
    • Dunlop SP, Jenkins D, Neal KR, Spiller RC: Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003, 125: 1651-1659.
    • (2003) Gastroenterology , vol.125 , pp. 1651-1659
    • Dunlop, S.P.1    Jenkins, D.2    Neal, K.R.3    Spiller, R.C.4
  • 14
    • 0033665517 scopus 로고    scopus 로고
    • Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome
    • Spiller RC, Jenkins D, Thornley JP, et al.: Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000, 47: 804-811.
    • (2000) Gut , vol.47 , pp. 804-811
    • Spiller, R.C.1    Jenkins, D.2    Thornley, J.P.3
  • 15
    • 0037378888 scopus 로고    scopus 로고
    • Increased rectal mucosal expression of interleukin 1 beta in recently acquired post-infectious irritable bowel syndrome
    • Gwee K-A, Collins SM, Read NW, et al.: Increased rectal mucosal expression of interleukin 1 beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003, 52: 523-526.
    • (2003) Gut , vol.52 , pp. 523-526
    • Gwee, K.-A.1    Collins, S.M.2    Read, N.W.3
  • 16
    • 35348846734 scopus 로고    scopus 로고
    • Bacteria: A new player in gastrointestinal motility disorders-infections, bacterial overgrowth and probiotics
    • QuigAey EM: Bacteria: a new player in gastrointestinal motility disorders-infections, bacterial overgrowth and probiotics. Gastroenterol Clin N Am 2007, 36: 735-748.
    • (2007) Gastroenterol Clin N Am , vol.36 , pp. 735-748
    • Quigley, E.M.1
  • 17
    • 0036083346 scopus 로고    scopus 로고
    • Activation of the mucosal immune system in irritable bowel syndrome
    • Chadwick V, Chen W, Shu D, et al.: Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002, 122: 1778-1783.
    • (2002) Gastroenterology , vol.122 , pp. 1778-1783
    • Chadwick, V.1    Chen, W.2    Shu, D.3
  • 18
    • 33846193703 scopus 로고    scopus 로고
    • Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome
    • Barbara G, Wang B, Stanghellini V, et al.: Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007, 132: 26-37.
    • (2007) Gastroenterology , vol.132 , pp. 26-37
    • Barbara, G.1    Wang, B.2    Stanghellini, V.3
  • 19
    • 33847342529 scopus 로고    scopus 로고
    • Role for protease activity in visceral pain in irritable bowel syndrome
    • Cenac N, Andrews CN, Holzhausen M, et al.: Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 2007, 117: 636-647.
    • (2007) J Clin Invest , vol.117 , pp. 636-647
    • Cenac, N.1    Andrews, C.N.2    Holzhausen, M.3
  • 20
    • 15744374565 scopus 로고    scopus 로고
    • A randomized, placebo-controlled, double-blind comparison of the probiotic bacteria lactobacillus and bifidobacterium in irritable bowel syndrome (IBS): Symptom responses and relationship to cytokine profiles
    • O'Mahony L, McCarthy J, Kelly P, et al.: A randomized, placebo-controlled, double-blind comparison of the probiotic bacteria lactobacillus and bifidobacterium in irritable bowel syndrome (IBS): symptom responses and relationship to cytokine profiles. Gastroenterology 2005, 128: 541-551.
    • (2005) Gastroenterology , vol.128 , pp. 541-551
    • O'Mahony, L.1    McCarthy, J.2    Kelly, P.3
  • 21
    • 33947324517 scopus 로고    scopus 로고
    • Immune activation in patients with irritable bowel syndrome
    • Liebregts T, Adam B, Bredack C, et al.: Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007, 132: 913-920.
    • (2007) Gastroenterology , vol.132 , pp. 913-920
    • Liebregts, T.1    Adam, B.2    Bredack, C.3
  • 22
    • 32044459306 scopus 로고    scopus 로고
    • Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: Plasma cytokines as a potential biomarker?
    • Dinan TG, Quigley EM, Ahmed SM, et al.: Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: Plasma cytokines as a potential biomarker? Gastroenterology 2006, 130: 304-311.
    • (2006) Gastroenterology , vol.130 , pp. 304-311
    • Dinan, T.G.1    Quigley, E.M.2    Ahmed, S.M.3
  • 23
    • 34447104397 scopus 로고    scopus 로고
    • The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects
    • Kassinen A, Krogius-Kurikka L, Mäkivuokko H, et al.: The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007, 133: 24-33.
    • (2007) Gastroenterology , vol.133 , pp. 24-33
    • Kassinen, A.1    Krogius-Kurikka, L.2    Mäkivuokko, H.3
  • 24
    • 34447106488 scopus 로고    scopus 로고
    • Irritable bowel syndrome: Shifting the focus toward the gut microbiota
    • Shanahan F: IrritablS bowel syndrome: shifting the focus toward the gut microbiota. Gastroenterology 2007, 133: 340-342.
    • (2007) Gastroenterology , vol.133 , pp. 340-342
    • Shanahan, F.1
  • 25
    • 34748841667 scopus 로고    scopus 로고
    • A 51-year-old with IBS. Test or treat for bacterial overgrowth?
    • Quigley EMM: A 51-year-old with IBS. Test or treat for bacterial overgrowth? Clin Gastroenterol Hepatol 2007, 5: 1140-1143.
    • (2007) Clin Gastroenterol Hepatol , vol.5 , pp. 1140-1143
    • Quigley, E.M.M.1
  • 26
    • 34249790127 scopus 로고    scopus 로고
    • Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
    • Posserud I, Stotzer PO, Bjornsson E, et al.: Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007, 56: 802-808.
    • (2007) Gut , vol.56 , pp. 802-808
    • Posserud, I.1    Stotzer, P.O.2    Bjornsson, E.3
  • 27
    • 41849111638 scopus 로고    scopus 로고
    • Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls
    • Bratten JR, Spanier J, Jones MP: Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol 2008, 103: 958-963.
    • (2008) Am J Gastroenterol , vol.103 , pp. 958-963
    • Bratten, J.R.1    Spanier, J.2    Jones, M.P.3
  • 28
    • 33846926968 scopus 로고    scopus 로고
    • Probiotics in irritable bowel syndrome: A rationale for their use and an assessment of the evidence to date
    • Quigley EMM, Flourie B: ProbioticsAin irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil 2007, 19: 166-172.
    • (2007) Neurogastroenterol Motil , vol.19 , pp. 166-172
    • Quigley, E.M.M.1    Flourie, B.2
  • 29
    • 0034767063 scopus 로고    scopus 로고
    • A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome
    • Niedzielin K, Kordecki H, Birkenfeld B: A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001, 13: 1143-1147.
    • (2001) Eur J Gastroenterol Hepatol , vol.13 , pp. 1143-1147
    • Niedzielin, K.1    Kordecki, H.2    Birkenfeld, B.3
  • 30
    • 0037392231 scopus 로고    scopus 로고
    • A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome
    • Kim HJ, Camilleri M, McKinzie S, et al.: A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003, 17: 895-904.
    • (2003) Aliment Pharmacol Ther , vol.17 , pp. 895-904
    • Kim, H.J.1    Camilleri, M.2    McKinzie, S.3
  • 31
    • 25844477007 scopus 로고    scopus 로고
    • A randomized controlled trial of probiotic combination VSL#3 and placebo in irritable bowel syndrome with bloating
    • Kim HJ, Vazquez Roque MI, Camilleri M, et al.: A randomized controlled trial of probiotic combination VSL#3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005, 17: 687-696.
    • (2005) Neurogastroenterol Motil , vol.17 , pp. 687-696
    • Kim, H.J.1    Vazquez Roque, M.I.2    Camilleri, M.3
  • 32
    • 24344472329 scopus 로고    scopus 로고
    • A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: A controlled 6-month intervention
    • Kajander K, Hatakka K, Poussa T, et al.: A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: A controlled 6-month intervention. Aliment Pharmacol Ther 2005, 22: 387-394.
    • (2005) Aliment Pharmacol Ther , vol.22 , pp. 387-394
    • Kajander, K.1    Hatakka, K.2    Poussa, T.3
  • 33
    • 50949100435 scopus 로고    scopus 로고
    • Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome
    • Feb 15 (Epub ahead of print)
    • Sinn DH, Song JH, Kim HJ, et al.: Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Dig Dis Sci 2008 Feb 15 (Epub ahead of print).
    • (2008) Dig Dis Sci
    • Sinn, D.H.1    Song, J.H.2    Kim, H.J.3
  • 34
    • 34447298145 scopus 로고    scopus 로고
    • Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: A multicentre, randomized, double-blind, controlled trial
    • Guyonnet D, Chassany O, Ducrotte P, et al.: Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: A multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 2007, 26: 475-486.
    • (2007) Aliment Pharmacol Ther , vol.26 , pp. 475-486
    • Guyonnet, D.1    Chassany, O.2    Ducrotte, P.3
  • 35
    • 33745569311 scopus 로고    scopus 로고
    • Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome
    • Whorwell PJ, Altinger L, Morel J, et al.: Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006, 101: 1581-1590.
    • (2006) Am J Gastroenterol , vol.101 , pp. 1581-1590
    • Whorwell, P.J.1    Altinger, L.2    Morel, J.3
  • 36
    • 36749082433 scopus 로고    scopus 로고
    • Clinical trial: Multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota
    • Kajander K, Myllyluoma E, Rajilic-Stojanovic M, et al.: Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 2008, 27: 48-57.
    • (2008) Aliment Pharmacol Ther , vol.27 , pp. 48-57
    • Kajander, K.1    Myllyluoma, E.2    Rajilic-Stojanovic, M.3
  • 37
    • 34447325957 scopus 로고    scopus 로고
    • Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome
    • Kajander K, Krogius-Kurikka L, Rinttilä T, et al.: Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Aliment Pharmacol Ther 2007, 26: 463-473.
    • (2007) Aliment Pharmacol Ther , vol.26 , pp. 463-473
    • Kajander, K.1    Krogius-Kurikka, L.2    Rinttilä, T.3
  • 38
    • 34547580948 scopus 로고    scopus 로고
    • Prescript-assist probiotic-prebiotic treatment for irritable bowel syndrome: An open-label, partially controlled, 1-year extension of a previously published controlled clinical trial/
    • Bittner AC, Croffut RM, Stranahan MC, Yokelson TN: Prescript-assist probiotic-prebiotic treatment for irritable bowel syndrome: An open-label, partially controlled, 1-year extension of a previously published controlled clinical trial. Clin Ther 2007, 29: 1153-1160.
    • (2007) Clin Ther , vol.29 , pp. 1153-1160
    • Bittner, A.C.1    Croffut, R.M.2    Stranahan, M.C.3    Yokelson, T.N.4
  • 39
    • 30944444119 scopus 로고    scopus 로고
    • Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice
    • Verdu EF, Bercik P, Verma-Gandhu M, et al.: Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 2006, 55: 182-190.
    • (2006) Gut , vol.55 , pp. 182-190
    • Verdu, E.F.1    Bercik, P.2    Verma-Gandhu, M.3
  • 40
    • 33846103017 scopus 로고    scopus 로고
    • Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity
    • Bueno L, de Ponti F, Fried M, et al.: Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Neurogastroenterol Motil 2007, 19(1 Suppl): 89-119.
    • (2007) Neurogastroenterol Motil , vol.19 , Issue.1 SUPPL. , pp. 89-119
    • Bueno, L.1    de Ponti, F.2    Fried, M.3
  • 41
    • 33846100339 scopus 로고    scopus 로고
    • Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
    • Rousseaux C, Thuru X, Gelot A, et al.: Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nature Med 2007, 13: 35-37.
    • (2007) Nature Med , vol.13 , pp. 35-37
    • Rousseaux, C.1    Thuru, X.2    Gelot, A.3
  • 42
    • 34547111846 scopus 로고    scopus 로고
    • Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation
    • Gareau MG, Jury J, MacQueen G, et al.: Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 2007, 56: 1522-1528.
    • (2007) Gut , vol.56 , pp. 1522-1528
    • Gareau, M.G.1    Jury, J.2    MacQueen, G.3
  • 43
    • 44949093373 scopus 로고    scopus 로고
    • The d-alanine content of lipoteichoic acid is crucial for Lactobacillus plantarum-mediated protection from visceral pain perception in a rat colorectal distension model
    • Feb 25 (Epub ahead of print)
    • Duncker SC, Wang L, Hols P, Bienenstock J: The d-alanine content of lipoteichoic acid is crucial for Lactobacillus plantarum-mediated protection from visceral pain perception in a rat colorectal distension model. Neurogastroenterol Motil 2008 Feb 25 (Epub ahead of print).
    • (2008) Neurogastroenterol Motil
    • Duncker, S.C.1    Wang, L.2    Hols, P.3    Bienenstock, J.4
  • 46
    • 0035050218 scopus 로고    scopus 로고
    • Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhea
    • Urbancsek H, Kazar T, Mezes I, et al.: Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhea. Eur J Gastroenterol Hepatol 2003, 13: 391-396.
    • (2003) Eur J Gastroenterol Hepatol , vol.13 , pp. 391-396
    • Urbancsek, H.1    Kazar, T.2    Mezes, I.3
  • 47
    • 33947521593 scopus 로고    scopus 로고
    • Use of probiotics for prevention of radiation-induced diarrhea
    • Delia P, Sansotta G, Donato V, et al.: Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 2007, 13: 912-915.
    • (2007) World J Gastroenterol , vol.13 , pp. 912-915
    • Delia, P.1    Sansotta, G.2    Donato, V.3
  • 48
    • 33846865120 scopus 로고    scopus 로고
    • Meta-analysis of probiotics for the prevention of traveler's diarrhea
    • McFarland LV: Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis 2007, 5: 97-105.
    • (2007) Travel Med Infect Dis , vol.5 , pp. 97-105
    • McFarland, L.V.1
  • 49
    • 33846287913 scopus 로고    scopus 로고
    • Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children
    • Szajewska H, Skorka A, Dylag M: Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 2007, 25: 257-264.
    • (2007) Aliment Pharmacol Ther , vol.25 , pp. 257-264
    • Szajewska, H.1    Skorka, A.2    Dylag, M.3
  • 50
    • 0037042674 scopus 로고    scopus 로고
    • Probiotics in prevention of antibiotic associated diarrhea: Meta-analysis
    • D'souza AL, Rajkumar CH, Cooke J, et al.: Probiotics in prevention of antibiotic associated diarrhea: Meta-analysis. BMJ 2002, 324: 1361-1366.
    • (2002) BMJ , vol.324 , pp. 1361-1366
    • D'souza, A.L.1    Rajkumar, C.H.2    Cooke, J.3
  • 51
    • 0036588144 scopus 로고    scopus 로고
    • Antibiotic associated diarrhea: A controlled study comparing plain antibiotic with those containing protected lactobacilli
    • Ahuja MC, Khamar B: AntibiAtic associated diarrhea: a controlled study comparing plain antibiotic with those containing protected lactobacilli. J Indian Med Assoc 2002, 100: 334-335.
    • (2002) J Indian Med Assoc , vol.100 , pp. 334-335
    • Ahuja, M.C.1    Khamar, B.2
  • 52
    • 33646713927 scopus 로고    scopus 로고
    • Efficacy of probiotics in prevention of acute diarrhoea: A meta-analysis of masked, randomised, placebo-controlled trials
    • Sazawal S, Hiremath G, Dhingra U, et al.: Efficacy of probiotics in prevention of acute diarrhoea: A meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006, 6: 374-382.
    • (2006) Lancet Infect Dis , vol.6 , pp. 374-382
    • Sazawal, S.1    Hiremath, G.2    Dhingra, U.3
  • 53
    • 33947169259 scopus 로고    scopus 로고
    • Probiotics and prebiotics: Effects on diarrhea
    • de Vrese M, Marteau PE: Probiotics and prebiotics: effects on diarrhea. J Nutr 2007, 137(3 Suppl 2): 803S-811S.
    • (2007) J Nutr , vol.137 , Issue.3 SUPPL. 2
    • de Vrese, M.1    Marteau, P.R.2
  • 54
    • 0346777280 scopus 로고    scopus 로고
    • Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation
    • Koebnick C, Wagner I, Leitzmann P, et al.: Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 2003, 17: 655-659.
    • (2003) Can J Gastroenterol , vol.17 , pp. 655-659
    • Koebnick, C.1    Wagner, I.2    Leitzmann, P.3
  • 55
    • 34047138836 scopus 로고    scopus 로고
    • Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight)
    • Amenta M, Cascio MT, Di Fiore P, Venturini I: Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight). Acta Biomed 2006, 77: 157-162.
    • (2006) Acta Biomed , vol.77 , pp. 157-162
    • Amenta, M.1    Cascio, M.T.2    Di Fiore, P.3    Venturini, I.4
  • 56
    • 14844303566 scopus 로고    scopus 로고
    • Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: A double-blind, placebo-controlled randomized trial
    • Banaszkiewicz A, Szajewska H: Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: A double-blind, placebo-controlled randomized trial. J Pediatr 2005, 146: 364-369.
    • (2005) J Pediatr , vol.146 , pp. 364-369
    • Banaszkiewicz, A.1    Szajewska, H.2
  • 57
    • 0035995860 scopus 로고    scopus 로고
    • Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly
    • Ouwehand AC, Lagstrom H, Suomalainen T, Salminen S: Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab 2002, 46: 159-162.
    • (2002) Ann Nutr Metab , vol.46 , pp. 159-162
    • Ouwehand, A.C.1    Lagstrom, H.2    Suomalainen, T.3    Salminen, S.4
  • 58
    • 3042511702 scopus 로고    scopus 로고
    • Bacteriotherapy using fecal flora: Toying with human motions
    • Borody TJ, Warren EF, Leis SM, et al.: Bacteriotherapy using fecal flora: Toying with human motions. J Clin Gastroenterol 2004, 38: 475-483.
    • (2004) J Clin Gastroenterol , vol.38 , pp. 475-483
    • Borody, T.J.1    Warren, E.F.2    Leis, S.M.3
  • 59
    • 25444502912 scopus 로고    scopus 로고
    • Review article: Bifidobacteria as probiotic agents - Physiological effects and clinical benefits
    • Picard C, Fioramonti J, Francois A, et al.: Review article: bifidobacteria as probiotic agents-physiological effects and clinical benefits. Aliment Pharmacol Ther 2005, 22: 495-512.
    • (2005) Aliment Pharmacol Ther , vol.22 , pp. 495-512
    • Picard, C.1    Fioramonti, J.2    Francois, A.3
  • 60
    • 33644878279 scopus 로고    scopus 로고
    • Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation
    • Khalif IL, Konovitch EA, Maximova ID, Quigley EMM: Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis 2005, 37: 838-849.
    • (2005) Dig Liver Dis , vol.37 , pp. 838-849
    • Khalif, I.L.1    Konovitch, E.A.2    Maximova, I.D.3    Quigley, E.M.M.4
  • 61
    • 33644910165 scopus 로고    scopus 로고
    • Germs, gas and the gut; the evolving role of the enteric flora in IBS
    • Quigley EM: Germs, gas and the gut; the evolving role of the enteric flora in IBS. Am J Gastroenterol 2006, 101: 334-335.
    • (2006) Am J Gastroenterol , vol.101 , pp. 334-335
    • Quigley, E.M.1
  • 62
    • 33846946465 scopus 로고    scopus 로고
    • Efficacy of probiotics and nutrients in functional gastrointestinal disorders: A preliminary clinical trial
    • Kim L, Hilli L, Orlowski J, et al.: Efficacy of probiotics and nutrients in functional gastrointestinal disorders: A preliminary clinical trial. Dig Dis Sci 2006, 51: 2134-2144.
    • (2006) Dig Dis Sci , vol.51 , pp. 2134-2144
    • Kim, L.1    Hilli, L.2    Orlowski, J.3
  • 63
    • 29244491643 scopus 로고    scopus 로고
    • Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication
    • Duman DG, Bor S, Ozütemiz O, et al.: Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication. Eur J Gastroenterol Hepatol 2005, 17: 1357-1361.
    • (2005) Eur J Gastroenterol Hepatol , vol.17 , pp. 1357-1361
    • Duman, D.G.1    Bor, S.2    Ozütemiz, O.3
  • 64
    • 34547569295 scopus 로고    scopus 로고
    • Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: A prospective randomized placebo-controlled double-blind study
    • Cindoruk M, Erkan G, Karakan T, et al.: Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: A prospective randomized placebo-controlled double-blind study. Helicobacter 2007, 12: 309-316.
    • (2007) Helicobacter , vol.12 , pp. 309-316
    • Cindoruk, M.1    Erkan, G.2    Karakan, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.